Stockreport

AbCellera Reports Full Year 2025 Business Results

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced financial results for the full year 2025. All financial information in this pr [Read more]